Stay updated with breaking news from Lars Wegner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Evaxion Biotech, Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update
Expanded DNA oncology vaccine program into non-small cell lung cancer, NSCLCAnnounced successful production of personalized cancer immunotherapies for melanomaAnnounced gonorrhea as second bacterial product
Investegate announcements from Evaxion Biotech, Evaxion Biotech A/S Announces Executive Management Changes
Investegate announcements from Evaxion Biotech, Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital
COPENHAGEN, Denmark, June 07, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-powered